Stem Cell Therapy for Treatment of Epilepsy
-
Parisa Goodarzi
,
Hamid Reza Aghayan
,
Masoud Soleimani
,
Abbas Norouzi-Javidan
,
Fereshteh Mohamadi-Jahani
,
Sharareh Jahangiri
,
Seyed Hasan Emami-Razavi
,
Bagher Larijani
,
Babak Arjmand
Abstract
Epilepsy as one of the most common neurological disorders affects more than 50 million people worldwide with a higher prevalence rate in low-income countries. Excessive electrical discharges in neurons following neural cell damage or loss cause recurrent seizures. One of the most common and difficult to treat types of epilepsy is temporal lobe epilepsy (TLE) which results from hippocampal sclerosis. Nowadays, similar to other diseases, epilepsy also is a candidate for treatment with different types of stem cells. Various stem cell types were used for treatment of epilepsy in basic and experimental researches. Two major roles of stem cell therapy in epilepsy are prophylaxis against chronic epilepsy and amelioration cognitive function after the occurrence of TLE. Several animal studies have supported the use of these cells for treating drug-resistant TLE. Although stem cell therapy seems like a promising approach for treatment of epilepsy in the future however, there are some serious safety and ethical concerns that are needed to be eliminated before clinical application.
Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet 2012;380(9848):1193-201.
Kuruba R, Hattiangady B, Shetty AK. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav 2009;14(Suppl 1):65-73.
Boison D, Stewart KA. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol 2009;78(12):1428-37.
Shetty AK. Progress in Cell Grafting Therapy for Temporal Lobe Epilepsy. Neurotherapeutics 2011;8(4):721-35.
Roper SN, Steindler DA. Stem cells as a potential therapy for epilepsy. Exp Neurol 2013:244(1):59-66.
Mac TL, Tran DS, Quet F, et al. Epidemiology, aetiology,and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 2007;6(6):533-43.
Carpio A, Hauser WA. Epilepsy in the developing world. Curr Neurol Neurosci Rep 2009;9(4):319-26.
Mohammadi MR, Ghanizadeh A, Davidian H, et al. Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 2006;15(7):476-82.
Li T, Steinbeck JA, Lusardi T, et al. Suppression of kindling epileptogenesis by adenosine releasing stem cellderived brain implants. Brain 2007;130(Pt 5):1276-88.
Van Dycke A, Raedt R, Verstraete A, et al. Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. Seizure-Eur J Epilep 2010;19(7):390-6.
Schmidt D. Efficacy of new antiepileptic drugs. Epilepsy Curr 2011;11(1):9-11.
Lagae L. Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy. Seizure 2006;15(4):235-41.
Mandelbaum DE, Burack GD, Bhise VV. Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Epilepsy Behav 2009;16(2):341-4.
Raedt R, Van Dycke A, Vonck K, et al. Cell therapy in models for temporal lobe epilepsy. Seizure 2007;16(7):565-78.
Venturin GT, Greggio S, Marinowic DR, et al. Bone marrow mononuclear cells reduce seizure frequency and improve cognitive outcome in chronic epileptic rats. Life Sci 2011;89(7-8):229-34.
Clusmann H. Predictors, procedures, and perspective for temporal lobe epilepsy surgery. Semin Ultrasound CT MR 2008;29(1):60-70.
Thompson K. Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy. Neurotherapeutics 2009;6(2):284-94.
Kriegstein AR, Pitkanen A. Commentary: The Prospect of Cell-Based Therapy for Epilepsy. Neurotherapeutics 2009;6(2):295-9.
Ghodsi M, Heshmat R, Amoli M, et al. The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up. Acta Med Iran 2012;50(8):541-6.
Aghayan HR, Arjmand B, Norouzi-Javidan A, et al. Clinical grade cultivation of human Schwann cell, by the using of human autologous serum instead of fetal bovine serum and without growth factors. Cell Tissue Bank 2012;13(2):281-5.
Saberi H, Firouzi M, Habibi Z, et al. Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J Neurosurg Spine 2011;15(5):515-25.
Saberi H, Moshayedi P, Aghayan HR, et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 2008;443(1):46-50.
Ruschenschmidt C, Koch PG, Brustle O, et al. Functional properties of ES cell-derived neurons engrafted into the hippocampus of adult normal and chronically epileptic rats. Epilepsia 2005;46(Suppl 5):174-83.
Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp 2000;231(1):7-15.
Ghosh D, Yan X, Tian Q. Gene regulatory networks in embryonic stem cells and brain development. Birth Defects Res C Embryo Today 2009;87(2):182-91.
Fedele DE, Koch P, Scheurer L, et al. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 2004;370(2-3):160-5.
Carpentino JE, Hartman NW, Grabel LB, et al. Regionspecific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures. J Neurosci Res 2008;86(3):512-24.
Naegele JR, Maisano X, Yang J, et al. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology 2010;58(6):855-64.
Hattiangady B, Rao MS, Shetty AK. Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp Neurol 2008;212(2):468-81.
Baraban SC, Southwell DG, Estrada RC, et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci U S A 2009;106(36):15472-7.
Chu K, Kim M, Jung KH, et al. Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats. Brain Res. 2004;1023(2):213-21.
Ardeshirylajimi A, Hosseinkhani S, Parivar K, et al. Nanofiber-based polyethersulfone scaffold and efficient differentiation of human induced pluripotent stem cells into osteoblastic lineage. Mol Biol Rep 2013;40(7):4287-94.
Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321(5893):1218-21. 34. Silva J, Barrandon O, Nichols J, et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008;6(10):e253.
Costa-Ferro ZS, Vitola AS, Pedroso MF, et al. Prevention of seizures and reorganization of hippocampal functions by transplantation of bone marrow cells in the acute phase of experimental epilepsy. Seizure 2010;19(2):84-92.
Li T, Ren G, Kaplan DL, et al. Human mesenchymal stem,cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res 2009;84(2-3):238-41.
Yazdani SO, Pedram M, Hafizi M, et al. A comparison between neurally induced bone marrow derived mesenchymal stem cells and olfactory ensheathing glial cells to repair spinal cord injuries in rat. Tissue Cell 2012;44(4):205-13.
Heile AM, Wallrapp C, Klinge PM, et al. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett 2009;463(3):176-81.
Jeon D, Chu K, Lee ST, et al. A cell-free extract from human adipose stem cells protects mice against epilepsy. Epilepsia 2011;52(9):1617-26.
Shafiee A, Seyedjafari E, Soleimani M, et al. A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue. Biotechnol Lett 2011;33(6):1257-64.
Boison D. Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics 2009;6(2):278-83.
Gallego JM, Sancho FJ, Vidueira S, et al. Injection of embryonic median ganglionic eminence cells or fibroblasts within the amygdala in rats kindled from the piriform cortex. Seizure 2010;19(8):461-6.
Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells freeof viral reprogramming factors. Cell 2009;136(5):964-77.
Krencik R, Zhang SC. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc 2011;6(11):1710-7.
Maisano X, Carpentino J, Becker S, et al. Embryonic stem cell-derived neural precursor grafts for the treatment of temporal lobe epilepsy. Neurotherapeutics 2009;6(2):263-77.
Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463(7284):1035-41.
| Files | ||
| Issue | Vol 52, No 9 (2014) | |
| Section | Articles | |
| Keywords | ||
| Cell therapy Epilepsy Stem cell Treatment | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
